Historical epidemiology of hepatitis C virus (HCV) in select countries -
volume 2

Saraswat, V.
Norris, S.
de Knegt, R. J.
Sanchez Avila, J. F.
and Sonderup, M.
Zuckerman, E.
Arkkila, P.
Stedman, C. and
Acharya, S.
Aho, I.
Anand, A. C.
Andersson, M. I. and
Arendt, V.
Baatarkhuu, O.
Barclay, K.
Ben-Ari, Z. and
Bergin, C.
Bessone, F.
Blach, S.
Blokhina, N.
Brunton,
C. R.
Choudhuri, G.
Chulanov, V.
Cisneros, L.
Croes, E.
A.
Dahgwahdorj, Y. A.
Dalgard, O.
Daruich, J. R. and
Dashdorj, N. R.
Davaadorj, D.
de Vree, M.
Estes, C. and
Flisiak, R.
Gadano, A. C.
Gane, E.
Halota, W.
Hatzakis,
A.
Henderson, C.
Hoffmann, P.
Hornell, J.
Houlihan, D.
and Hrusovsky, S.
Jarcuska, P.
Kershenobich, D.
Kostrzewska,
K.
Kristian, P.
Leshno, M.
Lurie, Y.
Mahomed, A. and
Mamonova, N.
Mendez-Sanchez, N.
Mossong, J.
Nurmukhametova,
E.
Nymadawa, P.
Oltman, M.
Oyunbileg, J.
Oyunsuren, Ts.
and Papatheodoridis, G.
Pimenov, N.
Prabdial-Sing, N.
Prins,
M.
Puri, P.
Radke, S.
Rakhmanova, A.
Razavi, H. and
Razavi-Shearer, K.
Reesink, H. W.
Ridruejo, E.
Safadi, R.
and Sagalova, O.
Sanduijav, R.
Schreter, I.
Seguin-Devaux,
C.
Shah, S. R.
Shestakova, I.
Shevaldin, A.
Shibolet, O.
and Sokolov, S.
Souliotis, K.
Spearman, C. W.
Staub, T. and
Strebkova, E. A.
Struck, D.
Tomasiewicz, K.
Undram, L. and
van der Meer, A. J.
van Santen, D.
Veldhuijzen, I.
Villamil,
F. G.
Willemse, S.
Zuure, F. R.
Silva, M. O.
Sypsa, V.
and Gower, E.

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2

Authors: V. Saraswat Norris, S. de Knegt, R. J. Sanchez Avila, J. F. and Sonderup, M. Zuckerman, E. Arkkila, P. Stedman, C. and Acharya, S. Aho, I. Anand, A. C. Andersson, M. I. and Arendt, V. Baatarkhuu, O. Barclay, K. Ben-Ari, Z. and Bergin, C. Bessone, F. Blach, S. Blokhina, N. Brunton, C. R. Choudhuri, G. Chulanov, V. Cisneros, L. Croes, E. A. Dahgwahdorj, Y. A. Dalgard, O. Daruich, J. R. and Dashdorj, N. R. Davaadorj, D. de Vree, M. Estes, C. and Flisiak, R. Gadano, A. C. Gane, E. Halota, W. Hatzakis, A. Henderson, C. Hoffmann, P. Hornell, J. Houlihan, D. and Hrusovsky, S. Jarcuska, P. Kershenobich, D. Kostrzewska, K. Kristian, P. Leshno, M. Lurie, Y. Mahomed, A. and Mamonova, N. Mendez-Sanchez, N. Mossong, J. Nurmukhametova, E. Nymadawa, P. Oltman, M. Oyunbileg, J. Oyunsuren, Ts. and Papatheodoridis, G. Pimenov, N. Prabdial-Sing, N. Prins, M. Puri, P. Radke, S. Rakhmanova, A. Razavi, H. and Razavi-Shearer, K. Reesink, H. W. Ridruejo, E. Safadi, R. and Sagalova, O. Sanduijav, R. Schreter, I. Seguin-Devaux, C. Shah, S. R. Shestakova, I. Shevaldin, A. Shibolet, O. and Sokolov, S. Souliotis, K. Spearman, C. W. Staub, T. and Strebkova, E. A. Struck, D. Tomasiewicz, K. Undram, L. and van der Meer, A. J. van Santen, D. Veldhuijzen, I. Villamil, F. G. Willemse, S. Zuure, F. R. Silva, M. O. Sypsa, V. and Gower, E.
Publication date: 1 January 2015
Publisher

Abstract

Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8666000 cases) and Russia (4162000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available

Similar works

Full text

Available Versions

Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens

oai:lib.uoa.gr:uoadl:3164600

Last time updated on 10/02/2023